Send us Feedback

Alexion Pharmaceuticals (ALXN)
Analysis
Data
Financials
No Sales Breakout Data.
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 124M 138M 139M 146M 166M
Short Term Investments 1.70M 0 0 0 0
Accounts Receivable 70.7M 74.5M 80.0M 95.0M 109M
Inventories 49.7M 49.8M 49.4M 45.5M 41.0M
Pre-paid Expenses 5.50M 13.8M 17.0M 13.0M 14.9M
Deferred Tax Assets 0 972K 0 979K 982K
Other Current Assets 18.6M 0 969K 0 0
Total Current Assets 270M 277M 286M 300M 332M
Property, Plant & Equipment 128M 140M 145M 155M 162M
Goodwill & Intangibles 29.9M 52.3M 51.1M 50.2M 49.2M
Other Long-term Assets 1.53M 4.89M 5.24M 9.13M 8.44M
Total Long-Term Assets 160M 200M 205M 215M 220M
Total Assets 430M 478M 492M 515M 552M
Accounts Payable 9.89M 33.7M 20.4M 9.16M 15.1M
Accrued Expenses 41.8M 0 0 0 0
Short Term Debt 7.29M 2.80M 2.80M 44.3M 20.5M
Other Current Liabilities 2.40M 1.77M 2.49M 3.33M 3.93M
Total Current Liabilities 61.4M 84.4M 70.1M 112M 108M
Long Term Debt 194M 141M 141M 9.92M 9.92M
Capital Lease Obligations 280K 203K 125K 44K 496K
Deferred Income Tax 0 906K 906K 923K 924K
Other Long-term Liabilities 916K 3.80M 4.59M 5.46M 5.49M
Total Long-term Liabilities 195M 146M 147M 16.3M 16.8M
Minority Interest 0 0 0 0 0
Total Liabilities 257M 231M 217M 129M 125M
Preferred Stock 0 0 0 0 0
Common Par 8K 5K 5K 5K 5K
Additional Paid-In Capital 882M 941M 955M 1.06B 1.08B
Retained Earnings -711M -696M -682M -665M -638M
Treasury Stock -1.26M -1.26M -2.33M -2.68M -2.68M
Other Equity 4.97M 2.95M 3.44M -5.41M -10.6M
Total Shareholder's Equity 174M 247M 275M 386M 427M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki